Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248185.RAFykh1z2A6LqHq5eVqAfCXkSoFrerBaDdh4i0-T2CxSU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248185.RAFykh1z2A6LqHq5eVqAfCXkSoFrerBaDdh4i0-T2CxSU130_assertion type Assertion NP1248185.RAFykh1z2A6LqHq5eVqAfCXkSoFrerBaDdh4i0-T2CxSU130_head.
- NP1248185.RAFykh1z2A6LqHq5eVqAfCXkSoFrerBaDdh4i0-T2CxSU130_assertion description "[TET2 functions as a bona fide tumor suppressor particularly in the pathogenesis of myeloid malignancies resembling chronic myelomonocytic leukemia (CMML) and myelodysplastic syndromes (MDS) in human.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248185.RAFykh1z2A6LqHq5eVqAfCXkSoFrerBaDdh4i0-T2CxSU130_provenance.
- NP1248185.RAFykh1z2A6LqHq5eVqAfCXkSoFrerBaDdh4i0-T2CxSU130_assertion evidence source_evidence_literature NP1248185.RAFykh1z2A6LqHq5eVqAfCXkSoFrerBaDdh4i0-T2CxSU130_provenance.
- NP1248185.RAFykh1z2A6LqHq5eVqAfCXkSoFrerBaDdh4i0-T2CxSU130_assertion SIO_000772 25510268 NP1248185.RAFykh1z2A6LqHq5eVqAfCXkSoFrerBaDdh4i0-T2CxSU130_provenance.
- NP1248185.RAFykh1z2A6LqHq5eVqAfCXkSoFrerBaDdh4i0-T2CxSU130_assertion wasDerivedFrom befree-2016 NP1248185.RAFykh1z2A6LqHq5eVqAfCXkSoFrerBaDdh4i0-T2CxSU130_provenance.
- NP1248185.RAFykh1z2A6LqHq5eVqAfCXkSoFrerBaDdh4i0-T2CxSU130_assertion wasGeneratedBy ECO_0000203 NP1248185.RAFykh1z2A6LqHq5eVqAfCXkSoFrerBaDdh4i0-T2CxSU130_provenance.